Hypera S.A. Hypera S.A.

Hypera S.A.

HYPE3

Pozycja w akcjach #4242
Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical... Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical enterprise. The company's comprehensive product line encompasses a wide array of prescription medications, featuring established brands such as Adacne, Celestamine, Cizax, Diprosone, and Emprol XR, among many others. Beyond prescription drugs, Hypera offers specialized dermo-cosmetics through its Mantecorp Skincare brand. Its consumer health division markets popular remedies like Apracur, Benegrip, Engov, and Estomazil. Additionally, Hypera provides nutritional and vitamin supplements, including well-known names such as Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal. The company also maintains a significant presence in the generic and similar medicines market, offering products under the Neo Química brand and common formulations like Ibuprofen, Paracetamol, and Omeprazole. The organization officially became Hypera S.A. in February 2018, having previously operated as Hypermarcas S.A.
Cena akcji
$5.32
Ostatnia synchronizacja: 2026-10-21
Kapitalizacja rynkowa
$3.74B
Zmiana (1 dzień)
2.01%
Zmiana (1 rok)
24.78%
Kraj
BR
Handel Hypera S.A. (HYPE3)

Kategoria

Healthcare
Historia ceny akcji dla Hypera S.A. (HYPE3)
Najwyższa cena zamknięcia: $5.03 dnia 2026-10-01

Najniższa cena zamknięcia: $4.81 dnia 2008-04-01
Historia cen akcji firmy Hypera S.A. od 2008 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -0.69%
2025 45.17%
2024 -58.10%
2023 -12.37%
2022 62.46%
2021 -21.43%
2020 -22.43%
2019 1.82%
2018 -25.66%
2017 46.20%
2016 28.75%
2015 -6.93%
2014 -19.33%
2013 0.07%
2012 62.59%
2011 -67.38%
2010 28.81%
2009 327.96%
2008 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$171.67 -
DE
$161.15 20.52%
DE
$39.98 41.43%
JP
$212.49 24.09%
CH
$19.19 -0.09%
IN